Krebs Biochemicals & Industries Ltd Quarterly Result
Krebs Biochemicals & Industries Ltd
NSE: KREBSBIO
Net Profit - Last Quarter
Krebs Biochemicals & Industries Ltd Quarterly Results Key Highlights
- The revenue of Krebs Biochemicals & Industries Ltd for the Mar '26 is ₹ 8.81 crore as compare to the Dec '25 revenue of ₹ 7.28 crore.
- This represent the growth of 21.02% The ebitda of Krebs Biochemicals & Industries Ltd for the Mar '26 is ₹ 1.14 crore as compare to the Dec '25 ebitda of ₹ 0.3 crore.
- This represent the growth of 280% The net profit of Krebs Biochemicals & Industries Ltd for the Mar '26 is ₹ -2.34 crore as compare to the Dec '25 net profit of ₹ -3.13 crore.
- This represent the decline of -25.24%.
Krebs Biochemicals & Industries Ltd Quarterly Results Analysis
Market Price of Krebs Biochemicals & Industries Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date | |
|---|---|
| 12 Jun 2026 | 64.06 |
| 11 Jun 2026 | 63.19 |
| 10 Jun 2026 | 66 |
| 09 Jun 2026 | 67.75 |
| 08 Jun 2026 | 66.35 |
| 05 Jun 2026 | 64.47 |
| 04 Jun 2026 | 65 |
| 03 Jun 2026 | 63.7 |
| 02 Jun 2026 | 64.71 |
| 01 Jun 2026 | 64.5 |
Historical Revenue of Krebs Biochemicals & Industries Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
Historical Revenue of Krebs Biochemicals & Industries Ltd
Historical EBITDA of Krebs Biochemicals & Industries Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Krebs Biochemicals & Industries Ltd
Historical Net Profit of Krebs Biochemicals & Industries Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Krebs Biochemicals & Industries Ltd
Krebs Biochemicals & Industries Ltd News Hub
Krebs Biochemicals & Industries reports standalone net loss of Rs 5.17 crore in the June 2024 quarter
Net Loss of Krebs Biochemicals & Industries reported to Rs 5.17 crore in the quarter ended June 2024
Read more
07 Aug 24
Krebs Biochemicals & Industries schedules AGM
Krebs Biochemicals & Industries announced that the 32th Annual General Meeting (AGM) of the company
Read more
09 Sept 24
Krebs Biochemicals & Industries to conduct board meeting
Krebs Biochemicals & Industries will hold a meeting of the Board of Directors of the Company on 11 N
Read more
29 Oct 24
Krebs Biochemicals & Industries reports standalone net loss of Rs 5.76 crore in the September 2024 quarter
Net Loss of Krebs Biochemicals & Industries reported to Rs 5.76 crore in the quarter ended September
Read more
11 Nov 24
Document
Popular Search
About Krebs Biochemicals & Industries Ltd
- Krebs Biochemicals & Industries Limited was initially incorporated as 'Krebs Biochemicals Limited' in 1991.
- The name of the Company was changed from Krebs Biochemicals Limited to Krebs Biochemicals & Industries Limited effected from November 21, 2003.
- Promoted by R T Ravi, Company engages in manufacture of Active Pharmaceutical Ingredients(API) through Fermentation process, one among very few in the world to do the same. The Company develops commercially viable biotech processes for application in medicine, agriculture and industry.
- Undertaking contract manufacturing for large pharmaceutical and multinational companies and developing products for sale in global markets, the Company possesses expertise and infrastructure in chemical synthesis, fermentation and enzymatic technologies. KBIL which commenced commercial operations in the year 1994 with an installed capacity of 60 TPA has now grown to 150 TPA.
